Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Prothena Announces up to $100 Million Share Repurchase Plan

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Biotechnology
Pharmaceutical
Health
Clinical Trials
Share Repurchase

More Like This

Business Wire logo

Prothena Announces Corporate Restructuring

Business Wire logo

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

Business Wire logo

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire logo

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Business Wire logo

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Business Wire logo

Prothena to Participate in Upcoming Healthcare Conferences

Business Wire logo

Prothena to Report Third Quarter 2024 Financial Results on November 12

Business Wire logo

Prothena to Report Third Quarter 2023 Financial Results on November 2

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us